Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheuminations: Epigenetics May Help to Explain Why Some Get Rheumatic Disease

Simon M. Helfgott, MD  |  Issue: March 2013  |  March 1, 2013

Even among those individuals who are homozygous for the HFE gene, less than one-third of men and only about 2% of women ever develop the disease.4 The HFE mutation may have provided an adaptive process to mitigate the decreased dietary iron concentration in cereal grain–based Neolithic diets. In fact, the C282Y mutation is estimated to have appeared at the beginning of the first millennia A.D., corresponding to the Roman warm period, when the northern European temperature was higher than any recorded in modern times. All of this is to say that our genes have interesting ways of interacting with their environment. So maybe Lamarck was correct?

Who Was Lamarck?

Jean-Baptiste Pierre Antoine de Monet, Chevalier de Lamarck, aka Lamarck, was an 18th-century biologist, best known for his theory of inheritance of acquired characteristics. He proposed that a complex alchemical force drove organisms up a ladder of complexity, while a second environmental force adapted them to local environments through the use and disuse of characteristics, differentiating them from other organisms. You may recall the classic example taught to high school biology students as a way to explain the concept of use and disuse; the elongated neck of the giraffe. According to La­marck’s theory, over a lifetime of straining to reach high branches, a giraffe could develop an elongated neck. But Lamarck could not explain how this might happen, though he discussed nature’s “natural tendency toward perfection.” Though historians credit Lamarck with developing one of the first, though flawed, theories of evolution, he died in poverty and obscurity. Although his theories have been debunked, he definitely was onto something. That something became known as the field of epigenetics, the gatekeeper of the genome.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Recent research suggests that the environment can make lasting changes to the genome via epigenetic mechanisms—changes that may be passed on to future generations.

Epigenetics: A New Frontier

Recent research suggests that the environment can make lasting changes to the genome via epigenetic mechanisms—changes that may be passed on to future generations.5 Epigenetic changes can range from chemical modifications of histone proteins—such as acetylation and methylation—to modifications made to the DNA itself. Such changes usually cause chromatin compaction, which limits the ability of the RNA polymerase II transcription complex to access DNA, ultimately resulting in reduced messenger RNA (mRNA) and protein output. Basically, epigenetics can define which genes may be silenced in order to enhance protein synthesis or eliminate redundancy. It cannot change the DNA, but can modify its reading.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Page: 1 2 3 4 5 6 7 | Single Page
Share: 

Filed under:OpinionResearch RheumRheuminationsSpeak Out Rheum Tagged with:epigeneticsResearchRheumatic Disease

Related Articles
    Kateryna Kon / Shutterstock.com

    How to Manage, Treat Anemia of Inflammation in Patients with Rheumatic Disease

    December 17, 2017

    Anemia is common in patients with systemic rheumatic disease, yet it may not get the attention it deserves. Anemia can result from chronic inflammation, treatment side effects or other disease factors, or it may signal an unrelated condition. Although diagnosis and treatment of anemia are sometimes challenging, clinicians must do their utmost to rigorously investigate…

    The Latest on Epigenetics in Immune-Mediated Disease

    March 19, 2019

    CHICAGO—Because the epigenome has been implicated in a variety of rheumatic conditions, a Basic Research Conference was convened on Epigenetics in Immune-Mediated Disease in conjunction with the 2018 ACR/ARHP Annual Meeting. Melanie Ehrlich, PhD, professor of human genetics and genomics at Tulane University School of Medicine, New Orleans, opened the conference. She has a long…

    A 52-Year-Old Lupus Paper Remains Important Today

    December 14, 2020

    Over 50 years ago, an article appeared in The New England Journal of Medicine: “Immunologic Factors and Clinical Activity in Systemic Lupus Erythema­tosus.”1 Written by a young postdoctoral fellow, Peter H. Schur, MD, and colleagues, the article synthesized important work in the field at the time. What follows is a discussion of the historical context…

    Drug Commercials—How Are They Still a Thing?

    July 19, 2018

    Picture this: It’s 3 o’clock in the morning. You can’t sleep. You settle in front of the television to watch a rerun of Dirty Dancing. And then it hits you: Ask your doctor. Even as your eyelids sag, some part of your primitive forebrain snaps to attention. Medical training has turned us all into multitaskers,…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences